TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9311401

Group type: EXPERIMENTAL
Intervention: Magnesium laevulinate (initial bolus 8 mmol: then 8 mmol/h)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Magnesium laevulinate
Number of subjects: 24
Study: 8513849

Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 mg
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 mg plus Hydrochlorothiazide 12.5 mg
Number of subjects: 87
Study: 3644367

Group type: EXPERIMENTAL
Intervention: Choice condition (selected from three equally effective preparations)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Instruction only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Information condition (same sensation information as choice)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choice condition (for high DFC patients)
Number of subjects: 0
Study: 29775076

Group type: EXPERIMENTAL
Intervention: Walking with breathing intervention for 12 weeks
Number of subjects: 90
Study: 28815307

Group type: EXPERIMENTAL
Intervention: Local Anesthesia with Monitored Anesthesia Care (LA-MAC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 60
Study: 23742125

Group type: EXPERIMENTAL
Intervention: Polyurethane film surgical dressing (Opsite Post‐Op Visible)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gauze and tape surgical dressings
Number of subjects: 0
Study: 24004888

Group type: EXPERIMENTAL
Intervention: 766 mg total blueberry polyphenols
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 1278 mg total blueberry polyphenols
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 1791 mg total blueberry polyphenols
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control drink (0 mg total blueberry polyphenols)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 319 mg total blueberry polyphenols
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 637 mg total blueberry polyphenols
Number of subjects: 21
Study: 21961484

Group type: EXPERIMENTAL
Intervention: Exenatide 10 μg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg orally (positive control)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Plasma glucose
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Plasma insulin
Number of subjects: 62
Study: 18182963

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Clonidine + Methylphenidate
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 16540710

Group type: EXPERIMENTAL
Intervention: Hypoxic group (inspired O2 fraction = 14.5%, n = 9)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normoxic group (inspired O2 fraction = 20.9%, n = 6)
Number of subjects: 15
Study: 12699262

Group type: EXPERIMENTAL
Intervention: Low-dose monophasic oral contraceptive continuously
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Progestins (oral, intramuscular, or IUD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GnRH agonist with immediate add-back therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeat surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical therapy postoperatively
Number of subjects: 0
Study: 10823097

Group type: EXPERIMENTAL
Intervention: Acupressure at the P6 point
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 8613630

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide nasal spray (110 micro g in each nostril once daily)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide nasal spray
Number of subjects: 239

Group type: COMPARATOR
Intervention: Astemizole (10 mg once daily)
Number of subjects: 239
Study: 1358234

Group type: EXPERIMENTAL
Intervention: Balsalazide 4 g/day
Number of subjects: 133

Group type: COMPARATOR
Intervention: Balsalazide 2 g/day
Number of subjects: 133
Study: 3965343

Group type: EXPERIMENTAL
Intervention: Golytely lavage (3‐4 L)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard preparation (48‐h clear liquid diet, 240 ml of magnesium citrate and 'X‐Prep' senna derivative)
Number of subjects: 18
Study: 31375142

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (Early-PN)
Number of subjects: 4640

Group type: COMPARATOR
Intervention: Late parenteral nutrition (Late-PN)
Number of subjects: 4640

Group type: EXPERIMENTAL
Intervention: Infection or IFI
Number of subjects: 4640

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 4640
Study: 29805085

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) using JCP droplets or HDM tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26117308

Group type: EXPERIMENTAL
Intervention: Heavy drinkers (HD)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Heavy drinkers (HD) with high AUD symptoms
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Heavy drinkers (HD) with low AUD symptoms
Number of subjects: 156

Group type: COMPARATOR
Intervention: Light drinkers (control)
Number of subjects: 156
Study: 24185212

Group type: EXPERIMENTAL
Intervention: acu-TENS on right LI4 and LI11 points
Number of subjects: 36

Group type: COMPARATOR
Intervention: acu-TENS to bilateral kneecaps
Number of subjects: 36

Group type: COMPARATOR
Intervention: sham acu-TENS on right LI4 and LI11 points
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Overall C‐MMASS indices for experimental, control, and placebo groups
Number of subjects: 36
Study: 22085595

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (Med Diet) enriched in MUFA with virgin olive oil
Number of subjects: 20
Study: 20463579

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate
Number of subjects: 134

Group type: COMPARATOR
Intervention: Immediate-release oral morphine sulfate
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Pain Relief Verbal Response Scale
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Global Medication Performance Scale
Number of subjects: 134
Study: 18595975

Group type: EXPERIMENTAL
Intervention: Oral corticosteroid bursts (0, 1 to 4, and >=5 courses)
Number of subjects: 877

Group type: EXPERIMENTAL
Intervention: Cumulative inhaled corticosteroid use
Number of subjects: 877
Study: 16091765

Group type: EXPERIMENTAL
Intervention: Rapeseed oil diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: Olive oil diet
Number of subjects: 9
Study: 11892372

Group type: EXPERIMENTAL
Intervention: Management of foot ulcers in patients with diabetes
Number of subjects: 100000
Study: 10510577

Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) injection with concentrated PHKCV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) injection with concentrated PHKCV after boosting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Five routine doses of rabies vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) two or three doses after i.d. 0.1 mL nonconcentrated PHKCV
Number of subjects: 0
Study: 8610079

Group type: EXPERIMENTAL
Intervention: 3‐hr training program on physicians' lipid intervention knowledge, attitudes, and skills
Number of subjects: 0
Study: 1436604

Group type: EXPERIMENTAL
Intervention: 300 mg of UDCA‐hemisuccinate orally twice a day for six months
Number of subjects: 36

Group type: COMPARATOR
Intervention: 200 mg of S‐adenosyl‐methionine (SAMe) twice a day for six months
Number of subjects: 36
Study: 3548109

Group type: EXPERIMENTAL
Intervention: Conventional pancreatic enzyme preparation (Pankreon 700; 3 X 3 dragees daily) with cimetidine (300 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: New pH-sensitive enzyme preparation (Kreon; 3 X 6 capsules daily) comprising acid-protected granules
Number of subjects: 8

Group type: COMPARATOR
Intervention: Conventional pancreatic enzyme preparation (Pankreon 700; 3 X 3 dragees daily) without cimetidine
Number of subjects: 8
Study: 31384878

Group type: EXPERIMENTAL
Intervention: Low Dose (LD) group - 2.5 × 10^9 CFU
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High Dose (HD) group - 1 × 10^10 CFU
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 90
Study: 29132175

Group type: EXPERIMENTAL
Intervention: 2L PEG plus simethicone
Number of subjects: 579

Group type: COMPARATOR
Intervention: 2L PEG
Number of subjects: 579
Study: 27272714

Group type: EXPERIMENTAL
Intervention: 20-gauge vitrectomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: 25-gauge vitrectomy
Number of subjects: 50
Study: 23740093

Group type: EXPERIMENTAL
Intervention: Dysfunction markers (comorbidity, medication consumption, doctor's visits, difficulties in activities of daily living)
Number of subjects: 1369

Group type: EXPERIMENTAL
Intervention: Dysfunction markers
Number of subjects: 1369
Study: 23330127

Group type: EXPERIMENTAL
Intervention: Carnosine added to treatment protocol for chronic brain ischemia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no carnosine)
Number of subjects: 0
Study: 20426644

Group type: EXPERIMENTAL
Intervention: Carotid angioplasty with stent placement (CAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0
Study: 18703676

Group type: EXPERIMENTAL
Intervention: Low-frequency pulsed currents (LPC) with a 50-Hz pulse frequency
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Russian current (RC) burst modulated at 50 Hz with 25 cycles per burst
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: KACs modulated at 20 Hz
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: KACs modulated at 50 Hz with 10 cycles per burst
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: KACs modulated at 20 Hz with 10 cycles per burst
Number of subjects: 26
Study: 15905297

Group type: EXPERIMENTAL
Intervention: Assisted hatching (laser system)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Zona intact (control)
Number of subjects: 60
Study: 12618251

Group type: EXPERIMENTAL
Intervention: Desogestrel (DSG)
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: Norgestimate (NGM)
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: Gestodene (GSD)
Number of subjects: 707

Group type: COMPARATOR
Intervention: Levonorgestrel (LNG)
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: Ethinylestradiol (50 microg)
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: Ethinylestradiol (30 microg)
Number of subjects: 707
Study: 9469691

Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam
Number of subjects: 197

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 197
Study: 7999656

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine and morphine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intramuscular morphine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 32
Study: 2967781

Group type: EXPERIMENTAL
Intervention: Tizanidine (4 mg three times daily) plus ibuprofen (400 mg three times daily)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo plus ibuprofen (400 mg three times daily)
Number of subjects: 105
Study: 31866441

Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 0
Study: 29884608

Group type: EXPERIMENTAL
Intervention: HeLP-Diabetes (interactive, theoretically-informed Web-based self-management program)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Usual care plus access to a comparator website (basic information only)
Number of subjects: 374
Study: 28177710

Group type: EXPERIMENTAL
Intervention: 5 g of bioactive collagen peptides (BCP) per day for 12 weeks
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 26116829

Group type: EXPERIMENTAL
Intervention: Homemade chicken liver baby food (CLBF)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ground beef baby food (GBBF)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mothers' preferences for liver and beef
Number of subjects: 50
Study: 23538593

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 21906250

Group type: EXPERIMENTAL
Intervention: Implantable hemodynamic monitoring (IHM) system used in treatment group
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group without access to hemodynamic information
Number of subjects: 400
Study: 18316672

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 16928485

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 222

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 222
Study: 14512859

Group type: EXPERIMENTAL
Intervention: Educational interventions
Number of subjects: 78

Group type: COMPARATOR
Intervention: Practice nurses
Number of subjects: 78
Study: 11153617

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 150 mg/kg iv bolus over 15 mins and continuous infusion of 12.5 mg/kg/hr over 90 mins (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 30)
Number of subjects: 60
Study: 9357882

Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 302

Group type: COMPARATOR
Intervention: Standard clinical practice (SP group)
Number of subjects: 302
Study: 8297924

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: COMPARATOR
Intervention: Moclobemide
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Non-responders (Amitriptyline, Placebo, Moclobemide)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Weight change
Number of subjects: 39
Study: 3552839

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK YES)
Number of subjects: 209

Group type: COMPARATOR
Intervention: No Streptokinase (SK NO)
Number of subjects: 209
Study: 30071843

Group type: EXPERIMENTAL
Intervention: How-to Parenting Program (7-week group intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: How-to Parenting Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention during the trial)
Number of subjects: 0
Study: 27276028

Group type: EXPERIMENTAL
Intervention: Water, sanitation, and hygiene intervention (adherence to two or three components)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Water, sanitation, and hygiene intervention (adherence)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control arm (zero or one intervention component)
Number of subjects: 185
Study: 25393622

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tacrolimus/MMF/steroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tacrolimus/MMF/steroids + Rituximab
Number of subjects: 0
Study: 23732255

Group type: EXPERIMENTAL
Intervention: Mesita Azul ultraviolet-disinfection system
Number of subjects: 444
Study: 20432107

Group type: EXPERIMENTAL
Intervention: National Youth Anti‐Drug Media Campaign (NYADMC) awareness
Number of subjects: 0
Study: 18953854

Group type: EXPERIMENTAL
Intervention: Metoprolol (oral or intravenous) administered from 2 hours before surgery to 30 days after surgery, dosage adjusted according to blood pressure and heart rate.
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (blank control group) receiving no metoprolol.
Number of subjects: 102
Study: 17273608

Group type: COMPARATOR
Intervention: 200 microg of spray fenoterol (n = 41)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 12 microg of dry‐powder inhaler formoterol (n = 43)
Number of subjects: 84
Study: 12966259

Group type: EXPERIMENTAL
Intervention: 1% AMI
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.5% KET
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination AMI 1%/KET 0.5%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination cream (open-label phase)
Number of subjects: 20
Study: 10100330

Group type: EXPERIMENTAL
Intervention: Intervention course (behavior change skills taught in weekly lectures and peer-led labs)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Control course (knowledge-oriented)
Number of subjects: 338
Study: 8875970

Group type: EXPERIMENTAL
Intervention: Cholesterol lowering interventions (low-fat/low-cholesterol diet, partial ileal bypass surgery, pharmacologic agents such as bile resins, fibrates, niacin, and HMG-CoA reductase inhibitors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HMG-CoA reductase inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholesterol lowering interventions
Number of subjects: 0
Study: 1725202

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Atenolol (50 mg)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Captopril (25 mg b.i.d.)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Diuretic (hydrochlorothiazide 50 mg and amiloride 5 mg)
Number of subjects: 503
Study: 7200722

Group type: EXPERIMENTAL
Intervention: Soy protein isolate diet
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Soy protein concentrate diet
Number of subjects: 57

Group type: COMPARATOR
Intervention: Casein diet
Number of subjects: 57
Study: 29693303

Group type: EXPERIMENTAL
Intervention: Abnormal SOFA coagulation score (SOFA-CS ≥ 1)
Number of subjects: 1508

Group type: EXPERIMENTAL
Intervention: Decline of ≥60% in platelet counts
Number of subjects: 1508

Group type: COMPARATOR
Intervention: Normal SOFA coagulation score (SOFA-CS = 0)
Number of subjects: 1508
Study: 29600318

Group type: EXPERIMENTAL
Intervention: Endoscopic submucosal diathermy (ESMD)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Endoscopic submucosal resection (ESMR)
Number of subjects: 29
Study: 26293682

Group type: EXPERIMENTAL
Intervention: DXA scans (spine, hip, whole body and forearm)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: HR‐pQCT scans (distal radius and tibia)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: QCT scans (spine and hip)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: TBS
Number of subjects: 125
Study: 24643055

Group type: EXPERIMENTAL
Intervention: Doxazosin for 4 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate for 4 weeks
Number of subjects: 80
Study: 21138499

Group type: EXPERIMENTAL
Intervention: Tiotropium plus formoterol
Number of subjects: 1868

Group type: COMPARATOR
Intervention: Tiotropium alone
Number of subjects: 1868
Study: 18047771

Group type: EXPERIMENTAL
Intervention: Active auditory verbal hallucinations (AVHs)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Identification of speaking voice as non-self
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Loudness and clarity of sound images
Number of subjects: 46
Study: 16150550

Group type: EXPERIMENTAL
Intervention: Burnout group
Number of subjects: 74

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 74
Study: 14510041

Group type: EXPERIMENTAL
Intervention: High-structure, behaviorally oriented (HSB) treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Low-structure, facilitative (LSF) treatment
Number of subjects: 120
Study: 11098028

Group type: EXPERIMENTAL
Intervention: Expectant management (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oral contraception (group B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment after second cycle
Number of subjects: 50
Study: 8884859

Group type: EXPERIMENTAL
Intervention: Aprotinin (group A, n = 46) - 2 x 10(5) KIU before incision, 2 x 10(6) KIU in priming solution, 5 x 10(5) KIU/h during CPB
Number of subjects: 93

Group type: COMPARATOR
Intervention: Normal saline (group B, n = 47)
Number of subjects: 93
Study: 1411667

Group type: EXPERIMENTAL
Intervention: 4 mg controlled-release salbutamol (CRS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 8 mg controlled-release salbutamol (CRS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo CRS
Number of subjects: 10
Study: 2865721

Group type: EXPERIMENTAL
Intervention: Propofol for induction and maintenance of anaesthesia, 9.0 mg/kg/h for 30 min followed by 4.5 mg/kg/h supplemented with fentanyl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 0
Study: 31524046

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PCB)
Number of subjects: 40
Study: 30383182

Group type: EXPERIMENTAL
Intervention: Imitated elicitation on the ISS
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Imitated elicitation on the ISS (M = 2:18 min, SD = 0:59 min)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Imitated productions
Number of subjects: 267

Group type: COMPARATOR
Intervention: Spontaneous productions
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Word-initial position
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Percentage of consonants correct across word positions
Number of subjects: 267
Study: 28452866

Group type: EXPERIMENTAL
Intervention: Dopamine reuptake inhibitor (methylphenidate)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Norepinephrine reuptake inhibitor (reboxetine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 26423001

Group type: EXPERIMENTAL
Intervention: Group Support Psychotherapy (GSP)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Group HIV Education (GHE)
Number of subjects: 109
Study: 23907995

Group type: EXPERIMENTAL
Intervention: 30 mg/kg eteplirsen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 mg/kg eteplirsen
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 20885302

Group type: EXPERIMENTAL
Intervention: Systematic feedback from standardized assessment tools
Number of subjects: 709

Group type: COMPARATOR
Intervention: Usual clinical practice (Control)
Number of subjects: 709
Study: 19219630

Group type: EXPERIMENTAL
Intervention: TENS (Transcutaneous Electrical Nerve Stimulation)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control (no further local treatment)
Number of subjects: 173
Study: 16325429

Group type: EXPERIMENTAL
Intervention: High-frequency acupoint stimulation (HF: 100 Hz)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-frequency acupoint stimulation (LF: 2 Hz)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Mock point stimulation
Number of subjects: 12